Completed PHASE4 INTERVENTIONAL 2-arm NCT04784988

Intensive Replacement Treatment in Haemophilia Patients With Synovitis

Sponsor: Federico II University

Interventions EHL-FVIII FVIII concentrate

Updated 5 times since 2021 Last updated: Mar 26, 2024 Started: Mar 1, 2022 Primary completion: Mar 1, 2023 Completion: Mar 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hemophilia A and is currently completed. Federico II University leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2024 — Jul 2024 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Apr 2023 — Apr 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Apr 2021 — Apr 2023 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federico II University

Data source: Federico II University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Napoli, Italy